$1.51
4.75% today
Nasdaq, Apr 03, 06:46 pm CET
ISIN
US09203E1055
Symbol
BDTX
Sector
Industry

Black Diamond Therapeutics Inc Target price 2025 - Analyst rating & recommendation

Black Diamond Therapeutics Inc Classifications & Recommendation:

Buy
100%

Black Diamond Therapeutics Inc Price Target

Target Price $13.40
Price $1.58
Potential
Number of Estimates 5
5 Analysts have issued a price target Black Diamond Therapeutics Inc 2026 . The average Black Diamond Therapeutics Inc target price is $13.40. This is higher than the current stock price. The highest price target is
$20.00 1,165.82%
register free of charge
, the lowest is .
A rating was issued by 6 analysts: 6 Analysts recommend Black Diamond Therapeutics Inc to buy, 0 to hold and 0 to sell.
Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis.
Analyst Estimates: Analysts believe that the Black Diamond Therapeutics Inc stock has an average upside potential 2026 of . Most analysts recommend the Black Diamond Therapeutics Inc stock at Purchase.

Earnings per share, P/E ratio and EV/sales Estimates 2025, 2026 to 2029

Create a premium account to unlock analyst estimates. Learn more

Quarter Annually
Dec '24 2025
Estimates
Earnings Per Share $ -1.27 -0.67
32.45% 47.24%
P/E negative
EV/Sales 0.38

6 Analysts have issued a Black Diamond Therapeutics Inc forecast for earnings per share. The average Black Diamond Therapeutics Inc EPS is

$-0.67
Unlock
. This is
47.24% higher
Unlock
than earnings per share in the financial year 2024. The highest EPS forecast is
$0.07 105.51%
Unlock
, the lowest is
$-1.32 3.94%
Unlock
.

This results in the following potential growth metrics and future valuations:

Earnings Per Share

2024 $-1.27 32.45%
2025
$-0.67 47.24%
Unlock
2026
$-1.08 61.19%
Unlock
2027
$-1.50 38.89%
Unlock
2028
$-1.57 4.67%
Unlock
2029
$-0.68 56.69%
Unlock

P/E ratio

Current -1.24 52.85%
2025
-2.37 91.13%
Unlock
2026
-1.47 37.97%
Unlock
2027
-1.05 28.57%
Unlock
2028
-1.01 3.81%
Unlock
2029
-2.33 130.69%
Unlock

Current Black Diamond Therapeutics Inc Upgrades & Downgrades

Create a Premium account to unlock Upgrades/Downgrades. Learn more
Analyst Rating Action Date
HC Wainwright & Co.
Locked
Locked
Locked Mar 18 2025
Stifel
Locked
Locked
Locked Mar 07 2025
HC Wainwright & Co.
Locked
Locked
Locked Nov 06 2024
HC Wainwright & Co.
Locked
Locked
Locked Oct 09 2024
Wedbush
Locked
Locked
Locked Oct 08 2024
HC Wainwright & Co.
Locked
Locked
Locked Sep 24 2024
Piper Sandler
Locked
Locked
Locked Sep 23 2024
Analyst Rating Date
Locked
HC Wainwright & Co.:
Locked
Locked
Mar 18 2025
Locked
Stifel:
Locked
Locked
Mar 07 2025
Locked
HC Wainwright & Co.:
Locked
Locked
Nov 06 2024
Locked
HC Wainwright & Co.:
Locked
Locked
Oct 09 2024
Locked
Wedbush:
Locked
Locked
Oct 08 2024
Locked
HC Wainwright & Co.:
Locked
Locked
Sep 24 2024
Locked
Piper Sandler:
Locked
Locked
Sep 23 2024

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today